Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

Pericarditis I: Introduction

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Myocarditis IV: Nursing Management

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

More Than an Effective Latch.

Nursing for women's health·2026

Same author

A Participatory Investigation of Breastfeeding Behavior in the Pakistani Community in the United Kingdom.

Journal of nutrition education and behavior·2026

Same author

Caregivers' views on paediatric burn injury prevention materials in the United Kingdom.

Burns : journal of the International Society for Burn Injuries·2026

Same author

Endometrial Endometrioid Carcinomas With Signet Ring Cells: Report of a Case Series With Detailed Clinical, Pathologic, and Molecular Analysis.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·2026

Same author

The association between cerebrospinal fluid interleukin-6, soluble interleukin-6 receptor, and interleukin-6 trans-signalling binary complex with postoperative delirium: an observational cohort study.

BJA open·2026

Same author

Status of Lactation Support for Urologists: Results and Recommendations From a Society of Women in Urology Parenting in Urology Task Force American Urologic Association Survey.

Urology·2026

Search research articles

Related Experiment Video

Updated: May 23, 2026

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

A cardiologist's quick guide to lupus.

Jennifer Taylor

European Heart Journal

|March 23, 2012

Summary

This summary is machine-generated.

Accelerated atherosclerosis is a significant issue for patients with lupus. This condition involves the rapid buildup of plaque in arteries, increasing cardiovascular risk.

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

Related Experiment Videos

Last Updated: May 23, 2026

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

Area of Science:

Cardiovascular Medicine
Rheumatology
Immunology

Background:

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
Patients with SLE exhibit a markedly increased risk of premature cardiovascular disease.
Accelerated atherosclerosis is a primary driver of this heightened cardiovascular morbidity and mortality in lupus.

Purpose of the Study:

To investigate the mechanisms underlying accelerated atherosclerosis in patients with systemic lupus erythematosus.
To identify key risk factors and biomarkers associated with early atherosclerotic development in SLE.
To explore potential therapeutic targets for mitigating cardiovascular complications in lupus.

Main Methods:

Systematic review of epidemiological studies and clinical trials.
Analysis of inflammatory pathways and immune cell involvement in lupus-associated atherosclerosis.
Evaluation of traditional and non-traditional cardiovascular risk factors in SLE cohorts.

Main Results:

Inflammation, immune dysregulation, and endothelial dysfunction are central to accelerated atherosclerosis in SLE.
Specific autoantibodies and elevated inflammatory markers are associated with increased atherosclerotic burden.
Traditional risk factors, when present, exacerbate cardiovascular risk in lupus patients.

Conclusions:

Accelerated atherosclerosis poses a major threat to the long-term health of individuals with systemic lupus erythematosus.
Comprehensive cardiovascular risk management, including aggressive control of inflammation and immune activity, is crucial.
Further research into targeted therapies is warranted to prevent and treat atherosclerosis in this vulnerable population.